Latest Communications News

Actinogen Medical (ASX:ACW) has clarified that no undisclosed information explains recent unusual trading in its shares, pointing instead to recent underwriting of options and published updates. The biotech also reaffirmed compliance with ASX rules and provided a detailed update on its lead Alzheimer’s drug Xanamem and ongoing clinical trials.

Endeavour Group confirms a fully franked dividend of AUD 0.012 per share for the six months ending June 2026, offering shareholders a choice of payment in Australian or New Zealand dollars based on their registered bank accounts.

WasteCo Group is raising $2 million through a share placement at $0.007 per share to finance a comprehensive turnaround and expansion plan amid ongoing financial challenges and a leadership overhaul.

WasteCo Group has initiated a $2 million share placement at $0.007 per share to fund its ambitious turnaround and growth strategy amid a FY 2026 loss. A Share Purchase Plan will follow, offering existing investors a chance to participate on the same terms.

Valiant Gold is fast-tracking the restart of its Comet Gold Mine in Western Australia, securing major infrastructure contracts and advancing technical studies to target production resumption by Q2 FY27.

GR Engineering Services launches a $10 million share purchase plan at the same price as a recent $100 million institutional placement, offering eligible shareholders a chance to invest up to $30,000 each.

Maritana Minerals is steadily progressing its Black Swan Processing Hub project, with demolition, earthworks, and procurement well underway, aiming for first gold production in the second half of 2027.

Perpetual Limited has updated its dividend announcement to confirm that the default payment method is cash rather than reinvestment, with a 63-cent unfranked dividend for the period ending June 2026.

Infotrust Ltd (ASX: ITS) reported a 9.8% rise in FY26 revenue to $64.1 million, powered by a strategic pivot to cyber security. The company exited its Cloud segment, repaid all bank debt, and acquired Catalyst Cyber to boost federal market presence, positioning for profitable growth in FY27.

Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.

AMCIL posted a $6.9 million profit for FY2026 while its portfolio returned negative 10%, underperforming the ASX 200. The company cut dividends to 4.0 cents fully franked, reshuffled holdings, and welcomed Alison Gibson as new CEO.

4DS Memory Limited is set to acquire Australian Edge-AI software firm Jenesys, raising $5 million to integrate its autonomous systems capabilities with 4DS’s PCMO ReRAM technology, targeting computing-in-memory and neuromorphic markets.